MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10735-026-10827-x

Медицинская библиотека · Journal of molecular histology · 2026

HECTD4 in human umbilical cord mesenchymal stem cells-derived exosomes alleviates osteoclast differentiation in osteoporosis progression by suppressing RANK m6A modification via promoting METTL3 ubiquitination.

Ma Fang, Yu Jun, Qin Yue, Ma Ye, Zhu Tao

СтатьяПеревод в очереди

Аннотация

Human umbilical cord mesenchymal stem cells-derived exosomes (UC-MSCs-exos) have demonstrated considerable potential in osteoporosis treatment. This study explored the underlying mechanisms of UC-MSCs-exos in this context. Osteoporosis cell models were established by treating RAW264.7 cells with RANKL, followed by incubation with UC-MSCs-exos. The effects on osteoclast differentiation were assessed via Western blot and TRAP staining. Transfection of HECTD4, METTL3, and RANK was performed to investigate the regulatory mechanism of UC-MSCs-exos on osteoclast differentiation. MeRIP-qPCR analyzed the impact of METTL3 on RANK m6A modification, and ubiquitination assays examined the influence of HECTD4 on METTL3 ubiquitination. Treatment with UC-MSCs-exos inhibited osteoclast differentiation in the osteoporosis models by decreasing the number of mature osteoclasts and markers such as RANK, ACP5, and CTSK. UC-MSCs-exos also reduced METTL3 levels in these models. When METTL3 was overexpressed in the presence of UC-MSCs-exos, osteoclast differentiation was enhanced. METTL3 promoted RANK protein stability by facilitating its m6A modification. In UC-MSCs-exos-treated models, RANK silencing reversed the effect of METTL3 overexpression on osteoclast differentiation. UC-MSCs-exos were found to contain abundant HECTD4, which promoted METTL3 degradation via ubiquitination. Silencing of HECTD4 promoted osteoclast differentiation in the presence of UC-MSCs-exos, but this was reversed by METTL3 silencing. HECTD4 from UC-MSCs-exos attenuated osteoclast differentiation in osteoporosis by inhibiting RANK m6A modification through METTL3 ubiquitination. These findings suggest that UC-MSCs-exos offer a promising strategy for osteoporosis treatment.

Для цитирования: Ma Fang, Yu Jun, Qin Yue, Ma Ye, Zhu Tao. HECTD4 in human umbilical cord mesenchymal stem cells-derived exosomes alleviates osteoclast differentiation in osteoporosis progression by suppressing RANK m6A modification via promoting METTL3 ubiquitination.. Journal of molecular histology. 2026. DOI: 10.1007/s10735-026-10827-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.